oncaspar
les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,
citra-lock 46.7% catheter lock solution 5ml vials
syner-med (pharmaceutical products) ltd -
citra-lock s 30% catheter lock solution for injection 2.5ml pre-filled syringes
syner-med (pharmaceutical products) ltd -
citra-lock s 46.7% catheter lock solution for injection 2.5ml pre-filled syringes
syner-med (pharmaceutical products) ltd -
zactran 150mgml solution for injection for cattle sheep and pigs
agritech enterprise sdn. bhd. - gamithromycin -
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile